Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

Authors: Mark N. Stein, Armelle Vinceneux, Debbie Robbrecht, Bernard Doger, Karen A. Autio, Michael T. Schweizer, Emiliano Calvo, Laura Medina, Marloes Van Dongen, Jean-Laurent Deville, Alice Bernard-Tessier, Debopriya Ghosh, Kristin Shotts, Fei Shen, Pharavee Jaiprasart, Ruchi Chaudhary, Shujian Wu, Leanne Cartee, Robert Schnepp, Daria Gaut, Josh Lauring, Sherry C. Wang, Victor M. Villalobos, Capucine Baldini

Published: 2025-06-01

DOI: 10.1200/jco-25-00678

Source: Full article

---

Abstract

PURPOSE